PolyPeptide Group AG (SWX: PPGN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
27.45
-0.50 (-1.79%)
Jan 29, 2025, 5:30 PM CET
72.53%
Market Cap 905.40M
Revenue (ttm) 311.55M
Net Income (ttm) -27.50M
Shares Out 32.98M
EPS (ttm) -0.84
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,550
Average Volume 30,799
Open 28.00
Previous Close 27.95
Day's Range 27.45 - 28.40
52-Week Range 14.56 - 35.80
Beta 1.11
RSI 51.82
Earnings Date Mar 11, 2025

About PolyPeptide Group AG

PolyPeptide Group AG operate as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of peptide-based therapies for metabolic disorders, including the GLP-1 receptor agonist drugs for the treatment of type 2 diabetes, obesity, and other co-morbidities, as well as oncology, hormonal disorde... [Read more]

Sector Healthcare
Founded 1952
Employees 1,273
Stock Exchange SIX Swiss Exchange
Ticker Symbol PPGN
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.